Category Archives: Events

Latest From Events

Natalie Ng wins the International BioGENEius Challenge

Natalie Ng

Today, Cupertino Junior Natalie Ng won the International BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research in biotechnology. Natalie’s research in breast cancer and biomarkers helped her stand out from the 13 other finalists from across the U.S., Canada and Australia competing for the Challenge’s top prize, a $7,500 cash award. The winner was named during the 2013 BIO International Convention’s keynote luncheon.  The International BioGENEius Challenges is one of Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Getting to Know Women in Bio

Getting to Know Women in Bio

We caught up with Women In Bio’s President, Phyllis Dillinger, to learn more about the group’s philosophy, agenda, programming and networking events Tell me about your organization and why it was founded. A few smart, entrepreneurial women in greater Washington, D.C. started Women In Bio in 2002 to meet like-minded women in the biosciences who could provide support for building their businesses. Since then, we’ve expanded our mission to include mentoring, networking and development opportunities Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO One-On-One Partnering Kicks Off!

Joe Colangelo

Partnering kicked off this today at the Business Forum at the 2013 BIO International Convention, and the numbers so far show that we have a strong week ahead of us. Over 130,000 partnering meeting requests have been requested Almost 22,000 meetings are already scheduled 4,900 of those meetings are exhibitor partnering meetings For a more in-depth look at the types of companies being represented at and stats on how many partnering meetings are taking place, check out this interview with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Expanding Access to Orphan Drugs

Orphan Drugs

At present many orphan diseases do not have any licensed treatments, and for those conditions where there is a therapy, it is often the only therapy in the class that is available. However, this is not always the case. In the field of blood-plasma proteins, therapies to treat hemophilia, alpha-1 deficiency and primary immune deficiencies have multiple innovator versions in a therapeutic class. Often one product in the class has received an orphan designation and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Our Health Care Ecosystem

Meekers

There are currently 907 drugs and vaccines targeting more than 100 diseases in development by U.S. biopharmaceutical companies. It is the first step on a path toward bringing much needed treatments to patients. However, with the current focus on the cost of health care, regulatory approval is not the final hurdle. Increasingly, the ability of patients to access new therapies is determined by those who pay for the treatments. Skyrocketing development costs, concerns about the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,